Opsonophagocytosis-inhibiting Mac protein of group A Streptococcus: Identification and characteristics of two genetic complexes

Infection and Immunity

Volumn 70, Issue 12, 2002, Pages 6880-6890

  Lei, Benfang ^a   DeLeo, Frank R ^a   Reid, Sean D ^a   Voyich, Jovanka M ^a   Magoun, Loranne ^b   Liu, Mengyao ^a   Braughton, Kevin R ^a   Ricklefs, Stacy ^a   Hoe, Nancy P ^a   Cole, Robert L ^a   Leong, John M ^b   Musser, James M ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGINYLGLYCYLASPARTIC ACID; BACTERIAL PROTEIN; CD11B ANTIGEN; CYSTEINE; EPITOPE; IMMUNOGLOBULIN G; INTEGRIN; MAC PROTEIN; MUTANT PROTEIN; PROTEINASE; REACTIVE OXYGEN METABOLITE; RECOMBINANT PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; AUTOOXIDATION; BACTERIAL GENE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC ANALYSIS; GENETIC IDENTIFICATION; GENETIC VARIABILITY; HOST PATHOGEN INTERACTION; HUMAN; HUMAN CELL; MOLECULAR CLONING; NEUTROPHIL; NONHUMAN; NUCLEOTIDE SEQUENCE; OPSONIZATION; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN INTERACTION; PROTEIN PURIFICATION; PROTEIN SYNTHESIS; PROTEIN VARIANT; SEQUENCE HOMOLOGY; STREPTOCOCCUS GROUP A;

AMINO ACID SEQUENCE; BACTERIAL PROTEINS; CELL LINE; HUMANS; INTEGRIN ALPHAVBETA3; MOLECULAR SEQUENCE DATA; NEUTROPHILS; OPSONIN PROTEINS; PHAGOCYTOSIS; PHARYNGITIS; PLATELET GLYCOPROTEIN GPIIB-IIIA COMPLEX; SEQUENCE ANALYSIS, DNA; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; VARIATION (GENETICS); VIRULENCE;

EID: 0036892238     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/IAI.70.12.6880-6890.2002     Document Type: Article

References (37)

1. Akesson, P., A. G. Sjoholm, and L. Bjorck. 1996. Protein SIC, a novel extracellular protein of Streptococcus pyogenes interfering with complement function. J. Biol. Chem. 271:1081-1088.
2. Beall, B., R. Facklam,T. Hoenes, and B. Schwartz. 1997. Survey of emm gene sequences and T-antigen types from systemic Streptococcus pyogenes infection isolates collected in San Francisco, California; Atlanta, Georgia; and Connecticut in 1994 and 1995. J. Clin. Microbiol. 35:1231-1235.
3. Beres, S. B., G. L. Sylva, K. D. Barbian, B. Lei, J. S. Hoff, N. D. Mammarella, M. Liu, J. C. Smoot, S. F. Porcella, L. D. Parkins, J. K. McCormick, D. Y. M. Leung, P. M. Schlievert, and J. M. Musser. 2002. Genome sequence of a serotype M3 strain of group A Streptococcus: Phage-encoded toxins, the high-virulence phenotype, and clone emergence. Proc. Natl. Acad. Sci. USA 99:10078-10083.
4. Boyum, A. 1968. Isolation of mononuclear cells and granulocytes from human blood. J. Clin. Lab. Investig. 21:77-89.
5. Chuntharapai, A., S. Bodary, M. Horton, and K. J. Kim. 1993. Blocking monoclonal antibodies to alpha V beta 3 integrin: A unique epitope of alpha V beta 3 integrin is present on human osteoclasts. Exp. Cell Res. 205:345-352.
6. 1 mediate attachment of Lyme disease spirochetes to human cells. Infect. Immun. 66:1946-1952.
7. Corbi, A. L., T. K. Kishimoto, L. J. Miller, and T. A. Springer. 1988. The human leukocyte adhesion glycoprotein Mac-1 (complement receptor type 3, CD11b) α subunit. Cloning, primary structure, and relation to the integrins, von Willebrand factor and factor B. J. Biol. Chem. 263:12403-12411.
8. Cunningham, M. W. 2000. Pathogenesis of group A streptococcal infections. Clin. Microbiol. Rev. 13:470-511.
9. Fernie-King, B. A., D. J. Seilly, C. Willers, R. Wurzner, A. Davies, and P. J. Lachmann. 2001. Streptococcal inhibitor of complement (SIC) inhibits the membrane attack complex by preventing uptake of C567 onto cell membranes. Immunology 103:390-398.
10. Hoe, N. P., P. Kordari, R. Cole, M. Liu, T. Palzkill, W. Huang, D. McLellan, G. J. Adams, M. Hu, J. Vuopio-Varkila, T. R. Cate, M. E. Pichichero, K. M. Edwards, J. Eskola, D. E. Low, and J. M. Musser. 2000. Human immune response to streptococcal inhibitor of complement, a serotype M1 group A Streptococcus extracellular protein involved in epidemics. J. Infect. Dis. 18:1425-1436.
11. Horstmann, R. D., H. J. Sievertsen, J. Knobloch, and V. A. Fischetti. 1988. Antiphagocytic activity of streptococcal M protein: Selective binding of complement control protein factor H. Proc. Natl. Acad. Sci. USA 85:1657-1661.
12. Horstmann, R. D., H. J. Sievertsen, M. Leippe, and V. A. Fischetti. 1992. Role of fibrinogen in complement inhibition by streptococcal M protein. Infect. Immun. 60:5036-5041.
13. Ji, Y., L. McLandsborough, A. Kondagunta, and P. P. Cleary. 1996. C5a peptidase alters clearance and trafficking of group A streptococci by infected mice. Infect. Immun. 64:503-510.
14. Kobayashi, S. D., J. M. Voyich, C. L. Buhl, R. M. Stahl, and F. R. DeLeo. 2002. Global changes in gene expression by human polymorphonuclear leukocytes during receptor-mediated phagocytosis: Cell fate is regulated at the level of gene expression. Proc. Natl. Acad. Sci. USA 99:6901-6906.
15. Lei, B., S. Mackie, S. Lukomski, and J. M. Musser. 2000. Identification and immunogenicity of group A Streptococcus culture supernatant proteins. Infect. Immun. 68:6807-6818.
16. Lei, B., F. R. DeLeo, N. P. Hoe, M. R. Graham, S. M. Mackie, R. L. Cole, M. Liu, H. R. Hill, D. E. Low, M. J. Federle, J. R. Scott, and J. M. Musser. 2001. Evasion of human innate and acquired immunity by a bacterial homologue of CD11b that inhibits opsonophagocytosis. Nat. Med. 7:1298-1305.
17. Levin, J. C., and M. R. Wessels. 1998. Identification of csrR/csrS, a genetic locus that regulates hyaluronic acid capsule synthesis in group A Streptococcus. Mol. Microbiol. 30:209-219.
18. Lukomski, S., N. P. Hoe, I. Abdi, J. Rurangirwa, P. Kordari, M. Liu, S. J. Dou, G. G. Adams, and J. M. Musser. 2000. Nonpolar inactivation of the hypervariable streptococcal inhibitor of complement gene (sic) in serotype M1 Streptococcus pyogenes significantly decreases mouse mucosal colonization. Infect. Immun. 68:535-542.
19. McCormick, J. K., J. M. Yarwood, and P. M. Schlievert. 2001. Toxic shock syndrome and bacterial superantigens: An update. Annu. Rev. Microbiol. 55:77-104.
20. Musser, J. M., A. R. Hauser, M. H. Kim, P. M. Schlievert, K. Nelson, and R. K. Selander. 1991. Streptococcus pyogenes causing toxic-shock-like syndrome and other invasive diseases: Clonal diversity and pyrogenic exotoxin expression. Proc. Natl. Acad. Sci. USA 88:2668-2672.
21. Musser, J. M., V. Kapur, J. Szeto, X. Pan, D. Swanson, and D. Martin. 1995. Genetic diversity and relationships among Streptococcus pyogenes strains expressing serotype M1 protein: Recent intercontinental spread of a subelone causing episodes of invasive disease. Infect. Immun. 63:994-1003.
22. Musser, J. M., and R. M. Krause. 1998. The revival of group A streptococcal diseases with a commentary on staphylococcal toxic shock syndrome, p. 185-218. In R. M. Krause and A. Fauci (ed.), Emerging Infections. Academic Press, San Diego, Calif.
23. Nei, M., and T. Gojobori. 1986. Simple methods for estimating the numbers of synonymous and nonsynonymous nucleotide substitutions. Mol. Biol. Evol. 3:418-426.
24. O'Toole, T. E., Y. Katagari, R. J. Faull, K., Peter, R. Tamura, V. Quaranta, J. C. Loftus, S. J. Shattil, and M. H. Ginsberg. 1994. Integrin cytoplasmic domains mediate inside-out signal transduction. J. Cell Biol. 124:1047-1059.
25. Reid, S. D., R. K. Selander, and T. S. Whittam. 1999. Sequence diversity of flagellin (fliC) alleles in pathogenic Escherichia coli. J. Bacteriol. 181:153-160.
26. Reid, S. D., N. P. Hoe, L. M. Smoot, and J. M. Musser. 2001. Group A Streptococcus: Allelic variation, population genetics, and host-pathogen interactions. J. Clin. Investig. 107:393-399.
27. Riddles, P. W., R. L. Blakeley, and B. Zerner. 1983. Reassessment of Ellman's reagent. Methods Enzymol. 91:49-60.
28. Sharkawy, A., D. E. Low, R. Saginur, D. Gregson, B. Schwartz, P. Jessamine, K. Green, and A. McGeer. 2002. Severe group A streptococcal soft-tissue infections in Ontario: 1992-1996. Clin. Infect. Dis. 34:454-460.
29. Smoot, J. C., K. D. Barbian, J. J. Van Gompel, L. M. Smoot, M. S. Chaussee, G. L. Sylva, D. E. Sturdevant, S. M. Mackie, S. F. Porcella, L. D. Parkins, S. B. Beres, D. S. Campell, T. M. Smith, Q. Zhang, V. Kapur, J. A. Daly, L. G. Veasy, and J. M. Musser. 2002. Genome sequence and comparative microarray analysis of serotype M18 group A Streptococcus strains associated with acute rheumatic fever outbreaks. Proc. Natl. Acad. Sci. USA 99:4668- 4673.
30. 3, Proc. Natl. Acad. Sci. USA 96:242-247.
31. Thompson, J. D., D. G. Higgins, and T. J. Gibson. 1994. CLUSTAL W: Improving the sensitivity of progressive multiple sequence alignment through sequence weighting, position-specific gap penalties and weight matrix choice. Nucleic Acids Res. 22:4673-4680.
32. van Eeden, S. F., M. E. Klut, B. Walker, and J. C. Hogg. 1999. The use of flow cytometry to measure neutrophil function. J. Immunol. Methods 242:23-43.
33. von Pawel-Rammingen, U., B. P. Johansson, and L. Björck. 2002. IdeS, a novel streptococcal cysteine proteinase with unique specificity for immunoglobulin G. EMBO J. 21:1607-1615.
34. Wexler, D. E., D. E. Chenoweth, and P. P. Cleary. 1985. Mechanism of action of the group A streptococcal C5a inactivator. Proc. Natl. Acad. Sci. USA 82:8144-8148.
35. Whitnack, E., and E. H. Beachey. 1982. Antiopsonic activity of fibrinogen bound to M protein on the surface of group A streptococci. J. Clin. Investig. 69:1042-1045.
36. Whittam, T. S., and M. Nei. 1991. Neutral mutation hypothesis test. Nature 354:114-116.
37. Xi, L., K. W. Cho, M. E. Herndon, and S.-C. Tu. 1990. Elicitation of an oxidase activity in bacterial luciferase by site-directed mutation of a noncatalytic residue. J. Biol. Chem. 265:4200-4203.